Antitrust enforcers at the U.S. Department of Justice seem no longer content to wade in only from afar and are ramping up efforts to push legal and policy priorities directly in private disputes.
Colin Kaepernick and Eric Reid have settled labor grievances alleging the NFL and its teams colluded to shut them out due to their protests during the national anthem, according to a joint statement Friday, giving the league an opening to distance itself from the controversy without a potentially damaging ruling on the collusion claims.
Boston Scientific Corp. revealed Friday that the Federal Trade Commission has asked for more info about its planned £3.3 billion ($4.2 billion) purchase of U.K.-based BTG PLC, saying the government is focused on certain types of tumor treatments sold by both companies.
Federal Trade Commission Republican Christine S. Wilson defended the current legal standard by which antitrust enforcers and courts judge mergers and anti-competitive conduct, but argued in a speech Friday that critics who want a new approach haven't given one alternative the attention it deserves.
Manhattan-based Amerra Capital Management and an Abu Dhabi-based investment firm won European Commission approval to take control of three Greek aquaculture companies on Friday, provided they offload some of the Mediterranean fish farms and small fish hatcheries.
A Delaware federal judge has dismissed a $50 million suit alleging LabCorp conspired with a Medicaid service management organization to impede a smaller laboratory services company from offering services in the state market, ruling the lab's antitrust claims lack standing and a relevant market.
A Florida federal judge called Rapture Electronic Music Festival’s antitrust claims against rival Ultra Enterprises Inc. “baseless” and dismissed its suit accusing Ultra and the city of Miami of conspiring to push Rapture out of a venue.
A New Jersey federal judge on Friday refused to pause a case accusing GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. of delaying the entry of generic alternatives to epilepsy drug Lamictal while the drugmakers try to appeal a class certification ruling to the Third Circuit.
A proposed class of diabetes patients who say three major insulin manufacturers caused them to overpay for the medication can’t pursue Racketeer Influenced and Corrupt Organizations Act claims against the drugmakers, a New Jersey federal judge said Friday, because the consumers didn’t buy the drugs directly from the companies.
An English appeals court on Friday upheld the Competition and Markets Authority’s £130,000 ($167,000) fine against a steel water tank manufacturer for illegally exchanging price information, saying it could find no basis for criticizing the penalty that the CMA had imposed.
Norton Rose Fulbright has brought into its Washington, D.C., office a veteran attorney with nearly two decades of experience as senior counsel for the Tennessee attorney general's office, as part of the firm's ongoing efforts to build a premier U.S. antitrust and competition practice.
BASF Corp. hit back at a patent infringement lawsuit in Delaware federal court Wednesday with antitrust counterclaims accusing its rival of illegally forcing customers to exclusively buy its automobile emissions capturing product.
A California federal court has paused a case alleging several airlines conspired to fix the prices of trans-Pacific flights after passengers said they have reached a settlement with the last carrier involved, All Nippon Airways Co., that will resolve their claims for $58 million.
A newly merged college marketing giant will add new competition controls to its internal policies as part of a deal it struck with the U.S. Department of Justice to end claims that, before the merger, its two now-component companies colluded to saddle colleges with expensive contracts.
Walgreen Co. and Kroger Co. have fired back at Johnson & Johnson's argument that the retailers don’t have the right to sue the drugmaker for antitrust violations on behalf of drug wholesalers, telling a Pennsylvania court Thursday that appeals courts have repeatedly ruled that they can.
A California federal judge will reconsider a $576.8 million bundle of antitrust settlements after the Ninth Circuit on Wednesday remanded a certification order and settlement approval for a class of indirect cathode ray tube purchasers.
Bumble Bee Foods LLC has reached a deal with Sysco Corp. to end claims that it colluded with other major tuna companies in a widespread conspiracy to keep prices for canned fish high.
The U.S. Department of Justice responded Wednesday to public comments filed about the deal allowing CVS Health Corp. to proceed with its $69 billion purchase of Aetna Inc., saying it still believes the fix being offered will cure any competitive concerns raised by the merger.
The U.K.'s Competition and Markets Authority said Thursday it's ready to take on the big, global cases that will fall in its lap after the country officially quits the European Union, but cautioned that a no-deal Brexit may "heavily constrain" the CMA's ability to tackle discretionary cases.
Austria’s competition authority is officially looking into whether Amazon is using its platform to favor its own products and strong arm others out of the way, the watchdog said Thursday.
A Delaware vice chancellor ruled Thursday that Blue Cross Blue Shield Association CEO Scott Serota must testify in an upcoming battle over the collapsed $54 billion merger of Cigna Corp. and Anthem Inc., in a decision that also clarified the court’s reach in compelling trial testimony.
The fight by many Democrats to push competition policy in a more populist direction helped spark a row at the Federal Trade Commission this week when members traded barbs over the agency’s split decision allowing Staples and its private equity backer to acquire office supply company Essendant.
The total value of fines levied by global enforcers for cartel conduct last year dropped slightly compared to 2017, but antitrust authorities still doled out significant penalties over both domestic and international activity, according to a report released Thursday by Morgan Lewis & Bockius LLP.
Justices Samuel Alito and Neil Gorsuch on Monday floated the idea of overruling the high court’s landmark Illinois Brick decision, which limits federal antitrust standing to direct purchasers, during oral arguments in a case accusing Apple Inc. of monopolizing the market for apps sold on its devices.
Recent case law reveals that courts vary widely in their approaches to shifting the costs and fees incurred in responding to a Federal Rule of Civil Procedure 45 subpoena. Nonparties responding to such requests should consider certain district court trends, say attorneys at Pepper Hamilton LLP.
"Echo of Its Time" is the story of Nebraska’s federal district court from statehood in 1867 to the demise of Prohibition in 1933. Professors John Wunder and Mark Scherer have written an objective, unsentimental and insightful history, layered with context and rich in character study, says U.S. District Judge Laurie Smith Camp of the District of Nebraska.
Lawyers involved in a mass tort must make difficult decisions concerning the potential size of the claimant pool, the expected percentage of qualifying cases, the likelihood of a settlement and more. Data analytics can help guide mass tort strategies and yield better outcomes, say Deb Zonies and Mark Zabel of litigation support services provider Verus LLC.
Many think that injunctions should not be allowed in standard-essential patent cases, but in order to protect the incentive to innovate, all owners of all patents need to be able to exercise their constitutional right to exclude, says Ken Stanwood, chief technology officer at WiLAN Inc.
Anthony Scaramucci is probably best known for the 11 days he spent as White House director of communications in 2017. But when White and Williams LLP attorney Randy Maniloff sat down to chat with "the Mooch," he was interested in hearing a different story.
Americans deserve legislation that addresses the costs of prescription drugs, but the compulsory licensing rules proposed by some members of Congress would discourage investment in the discovery of new life-saving drugs, says Sen. Thom Tillis, R-N.C.
A recent Federal Trade Commission enforcement action involving a vertical merger between Staples Inc. and Essendant Inc. highlighted the intensifying debate regarding vertical integration's competitive benefits and harms, as well as starkly divergent views between individual commissioners on merger review, say Daniel Hemli and Jacqueline Java at Bracewell LLP.
Paul Manafort's attorneys recently filed a court document containing incompletely redacted information, highlighting the need for attorneys to become competent at redaction — or at least at verifying that redaction has been performed correctly. Failure to do either could be construed as legal malpractice, says Byeongsook Seo of Snell & Wilmer LLP.
Even as a child in war-torn Iran, I began to develop a sense of justice and a desire for equality and the rule of law. These instincts ultimately guided me to become a federal prosecutor, and now a partner in private practice, says Raymond Aghaian of Kilpatrick Townsend & Stockton LLP.
Determining whether and to what extent your legal team should invite a PR agent into privileged communications requires weighing many factors — including the unsettled and evolving case law on whether such involvement destroys privilege protection and creates discoverable, usable evidence, says Jeffrey Schomig of WilmerHale.